These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35388589)
1. Adjunctive treatment for acne vulgaris by tranexamic acid. Charoenwattanayothin A; Saiwichai T; Chaichalotornkul S J Cosmet Dermatol; 2022 Oct; 21(10):4515-4522. PubMed ID: 35388589 [TBL] [Abstract][Full Text] [Related]
2. A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema. Agamia N; El-Nagdy S; El-Ariny A Dermatol Ther; 2022 Apr; 35(4):e15327. PubMed ID: 35060229 [TBL] [Abstract][Full Text] [Related]
3. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea. McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks. Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584 [TBL] [Abstract][Full Text] [Related]
5. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial. Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549 [TBL] [Abstract][Full Text] [Related]
7. Effects of 15% Azelaic Acid Gel in the Management of Post-Inflammatory Erythema and Post-Inflammatory Hyperpigmentation in Acne Vulgaris. Shucheng H; Zhou X; Du D; Li J; Yu C; Jiang X Dermatol Ther (Heidelb); 2024 May; 14(5):1293-1314. PubMed ID: 38734843 [TBL] [Abstract][Full Text] [Related]
8. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne. Mazzetti A; Moro L; Gerloni M; Cartwright M J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550 [TBL] [Abstract][Full Text] [Related]
9. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face. Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264 [TBL] [Abstract][Full Text] [Related]
11. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. Lucky AW; Henderson TA; Olson WH; Robisch DM; Lebwohl M; Swinyer LJ J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):746-54. PubMed ID: 9366821 [TBL] [Abstract][Full Text] [Related]
14. The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post-acne erythema: A split-face, double-blind, randomized, placebo-controlled trial. Washrawirul C; Puaratana-Arunkon T; Chongpison Y; Noppakun N; Asawanonda P; Kumtornrut C J Dermatol; 2023 Jun; 50(6):739-745. PubMed ID: 36806298 [TBL] [Abstract][Full Text] [Related]
15. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study. Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; BiaĆecka A; Kasprowicz A Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718 [TBL] [Abstract][Full Text] [Related]
16. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris. Sayyafan MS; Ramzi M; Salmanpour R J Dermatolog Treat; 2020 Nov; 31(7):730-733. PubMed ID: 30998422 [No Abstract] [Full Text] [Related]
17. Acne treatment efficacy of intense pulsed light photodynamic therapy with topical licochalcone A, l-carnitine, and decanediol: A spilt-face, double-blind, randomized controlled trial. Wanitphakdeedecha R; Tavechodperathum N; Tantrapornpong P; Suphatsathienkul P; Techapichetvanich T; Eimpunth S; Manuskiatti W J Cosmet Dermatol; 2020 Jan; 19(1):78-87. PubMed ID: 31587493 [TBL] [Abstract][Full Text] [Related]
18. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR; Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial. Li S; He X; Zhang Z; Zhang XS; Niu YG; Steel A; Wang HT J Cosmet Dermatol; 2023 Sep; 22(9):2502-2511. PubMed ID: 36999489 [TBL] [Abstract][Full Text] [Related]
20. A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging. King S; Campbell J; Rowe R; Daly ML; Moncrieff G; Maybury C J Cosmet Dermatol; 2023 Oct; 22(10):2650-2662. PubMed ID: 37550898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]